Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MIPD of Oral Ibuprofen for PDA
NCT07143201Phase 2Recruiting
- Sponsor
- Hamilton Health Sciences
- Start
- Jul 2024
- Primary completion
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ibuprofen in patent ductus arteriosus (PDA), sponsored by Hamilton Health Sciences. Started Jul 2024; status: recruiting.
02
Drugs
ibuprofen
03
Conditions
patent ductus arteriosus (PDA)
Beyond the preview
Go deeper on NCT07143201.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07143201.